Detalhe da pesquisa
1.
An exploration of factors influencing the selection of generic and innovator medicines in Saudi Arabia using an observational cross-sectional study.
Saudi Pharm J
; 32(4): 102021, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497088
2.
Fasting during Ramadan and acute kidney injury (AKI): a retrospective, propensity matched cohort study.
BMC Nephrol
; 23(1): 54, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125093
3.
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.
Saudi Pharm J
; 30(12): 1748-1754, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601502
4.
The impact of child-specific characteristics on warfarin dosing requirements.
Res Pract Thromb Haemost
; 8(1): 102321, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38371334
5.
Comparison of initial warfarin response in obese patients versus non-obese patients.
J Thromb Thrombolysis
; 36(1): 96-101, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23015280
6.
Validity and reliability of the Arabic-translated kidney disease quality of life survey among long-term dialysis patients in Saudi Arabia.
Saudi J Kidney Dis Transpl
; 32(5): 1365-1373, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35532706
7.
The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia.
Cureus
; 12(8): e10032, 2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983725
8.
Awareness of acute kidney injury risk factors and perspectives on its practice guidelines.
Hosp Pract (1995)
; 46(3): 137-143, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29688150
9.
Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study.
PLoS One
; 12(11): e0188390, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182650
10.
Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization.
Am J Med Sci
; 353(2): 172-177, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183419
11.
Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal disease.
Pharmacotherapy
; 34(7): 695-702, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24851819